Position in BIIB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$58,309,206
+$2,072,658 QoQ
Shares Held
318,056
-0.5% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99.85505697109943.ToString("F0")%
Shared 0.ToString("F0")%
None 0.14494302890057095.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FIL Ltd holds $2,178,098,286 across 11 Drug Manufacturers - General names. BIIB ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,654,855 | $918,030,501 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,278,815 | $380,810,128 | |
| 3 | PFE |
Pfizer Inc
|
8,751,327 | $245,737,262 | |
| 4 | LLY |
ELI LILLY & Co
|
191,147 | $175,811,276 | |
| 5 | ABBV |
AbbVie Inc.
|
570,535 | $124,085,657 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
875,527 | $122,022,197 | |
| 7 | MRK |
Merck & Co., Inc.
|
597,352 | $71,855,472 | |
| 8 | JNJ |
Johnson & Johnson
|
249,664 | $61,027,868 |
All Filings in BIIB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,309,206 | 318,056 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,236,548 | 319,544 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,144,219 | 307,997 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,685,655 | 244,332 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,420,800 | 120,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $16,013,323 | 104,717 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $37,993,027 | 196,002 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $183,278,049 | 790,605 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $151,461,099 | 702,412 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $169,883,021 | 656,502 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,280,040 | 63,344 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,226,412 | 63,986 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,762,502 | 63,887 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $15,236,969 | 55,023 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,957,692 | 52,276 | Shares | Defined | 2022-11-10 | |
| 2022-03-31 | $14,382,084 | 68,291 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,434,025 | 72,666 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,054,455 | 74,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,594,573 | 76,803 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $26,250,900 | 93,837 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $19,510,444 | 79,680 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $312,048 | 1,100 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $11,959,796 | 37,802 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||